Home » Topics » Regulatory » Patents

Patents
RSS

Platelet-activating factor receptor antagonists discovered at Boehringer Ingelheim

June 9, 2022

Ningbo Combireg Pharmaceutical Technology presents deuterated anticancer compounds

June 9, 2022

French researchers patent gold complexes and their use as antioxidants

June 9, 2022

CURACLE and collaborators patent carbazole derivative angiogenesis inhibitors

June 9, 2022

Humanwell Healthcare discloses LPAR1 antagonists

June 9, 2022

Korean research groups patent novel antioxidants

June 8, 2022

Janssen Pharmaceutica discloses MAP3K14 inhibitors

June 8, 2022

Foghorn Therapeutics describes SNF2L2/BRG1 inhibitors

June 8, 2022

University of California and University of Washington divulge IRE1 inhibitors

June 8, 2022

Southern Research Institute and UABRF report development of HO-1 modulators

June 8, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...